Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
about
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionDoes the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysisRole of aprotinin in the management of patients during and after cardiac surgery.Treatment of coronary heart disease with minimally invasive surgery.Aprotinin: is it prothrombotic?Aprotinin and major orthopedic surgeryRandomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?Modulation of systemic inflammatory response after cardiac surgery.Cost and utilization of blood transfusion associated with spinal surgeries in the United StatesPredicting and preventing adverse neurologic outcomes with cardiac surgery.Aprotinin in cardiac surgery.Safety aspects of aprotinin therapy in cardiac surgery patients.Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes.Benefits and risks of aprotinin use during cardiac surgery.The effect of antifibrinolytic prophylaxis on postoperative outcomes in patients undergoing cardiac operations.Why thrombin PAR1 receptors are important to the cardiac surgical patientAntifibrinolytic therapy: evidence, bias, confounding (and politics!).A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.Pharmacologic methods to reduce perioperative bleeding.Is aprotinin safe to use in a cohort at increased risk for thrombotic events: results from a randomized, prospective trial in off-pump coronary artery bypass.Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass.Local use of ankaferd blood clotter in emergent beating heart coronary artery bypass graftingLow dose aprotinin increases mortality and morbidity in coronary artery bypass surgery(*).A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.Heparin therapy during extracorporeal circulation: deriving an optimal activated clotting time during cardiopulmonary bypass for isolated coronary artery bypass grafting.Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.Chest pain after coronary artery bypass: relation to coping capacity and quality of life.Age and left ventricular impairment predict reopening for bleeding.Tranexamic acid and primary coronary artery bypass surgery: a prospective study.Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study.Near infrared fluorescence imaging with ICG in TECAB surgery using the da Vinci Si surgical system in a canine model.
P2860
Q24235627-F42F330C-E421-405A-84DE-79BC51262020Q28209982-B5B13C5A-E274-44B5-ABBB-4C85A5164EEFQ34181817-3DA7B77C-18DF-4F33-8BB4-A8D42D56AD49Q34212405-8E42FCB4-FD7B-4574-973F-CE8FBA99FE39Q34375495-91349EE0-142F-4DFC-82BA-ACB460B8FC06Q35827396-5EC646BA-1F2E-4EB3-A085-DF420AA7D0D6Q36309916-F641216B-6AEB-4882-B37E-14DBB57F84DBQ36320195-44DA20AA-4699-423B-A262-02A617C17F7DQ36384211-46B3054E-A8CB-427F-9A81-DA8A412C29DBQ36402657-91C9F178-FBDB-4497-B9EF-620CC1508A29Q36410418-838535C3-9300-40BD-B5BA-B912F40F121BQ36506820-BFCF6188-1F44-4CD6-9F21-6741C2DB2C05Q36521995-8F26FFA7-3129-4E4A-8AE2-C12E3DF56D24Q37043551-2D89F378-2452-42E5-B9FF-F86C12F7FE51Q37044816-E63581BD-56B7-4A92-A720-BCD5BE6A86D2Q37092160-143009EB-0691-48EB-B840-AE5E49F04691Q37092164-F6E5D03C-9F48-46DA-8931-BA8862CD8595Q37095548-1D7490D1-A32B-4C5B-BA6D-522EC29453B2Q37095552-D59B940C-35F9-4C3C-B822-0DA6729F7D4DQ37113633-74E7FA5B-95C4-4F44-BF47-D915CD0B897CQ37253019-8F1DF3DA-15E1-4651-B874-09B0EC809D28Q37339494-9588AB34-CECC-455A-A3B2-9F72F8402F88Q37946690-0EAB7F6D-71DD-48D1-9C59-599F8983779FQ41991153-9DD876E5-D9D7-4FA7-A4FD-175B745ABE04Q42127435-1AC41687-E5F7-4FDD-B161-7FFC62C4C75FQ42677479-A9103821-F683-431B-835C-202198FD673FQ43052506-981E6753-8272-4952-BBFA-391580322C23Q43171003-7E5E8D5B-D17C-4AD8-BCF2-EB941C902D17Q43651344-32D82DF6-02DC-4A43-A4A2-8D4FB4153725Q47739762-27DC94F0-2A91-4AD2-9273-5DA4330E209BQ48579170-8E8C8D89-BC48-469C-834B-BF777323D58CQ48822571-E1627626-DC9F-4D07-974E-B336CA0E8325Q50501668-8CE084CF-18F9-4220-9211-6C55DAFEF229
P2860
Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Analyses of coronary graft pat ...... ency Experience (IMAGE) trial.
@en
Analyses of coronary graft pat ...... tinin Graft Patency Experience
@nl
type
label
Analyses of coronary graft pat ...... ency Experience (IMAGE) trial.
@en
Analyses of coronary graft pat ...... tinin Graft Patency Experience
@nl
prefLabel
Analyses of coronary graft pat ...... ency Experience (IMAGE) trial.
@en
Analyses of coronary graft pat ...... tinin Graft Patency Experience
@nl
P2093
P1476
Analyses of coronary graft pat ...... ency Experience (IMAGE) trial.
@en
P2093
Alderman EL
Chaitman B
Hantler CB
Pettersson G
P304
P356
10.1016/S0022-5223(98)00431-0
P407
P577
1998-11-01T00:00:00Z